Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 2;15(1):115-116.
doi: 10.4103/ojo.ojo_108_21. eCollection 2022 Jan-Apr.

Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema

Ashley Khalili  1 , Reza Razeghinejad  2 , Zeba Almas Syed  1
Affiliations

Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema

Ashley Khalili et al. Oman J Ophthalmol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Slit-lamp photo of the right eye on presentation demonstrating limbus to limbus bullous reticular epithelial edema
Figure 2
Figure 2
Prominent bullous epithelial edema as visualized with anterior segment optical coherence tomography
Figure 3
Figure 3
Slit-lamp photo illustrating improvement of corneal edema after discontinuation of netarsudil
Figure 4
Figure 4
Anterior segment optical coherence tomography demonstrating resolution of the epithelial bullae after discontinuation of netarsudil
See this image and copyright information in PMC

References

    1. Hoy SM. Netarsudil ophthalmic solution 0.02%: First global approval. Drugs. 2018;78:389–96. - PubMed
    1. Serle JB, Katz LJ, McLaurin E, Heah T, Ramirez-Davis N, Usner DW, et al. Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2) Am J Ophthalmol. 2018;186:116–27. - PubMed
    1. Wisely CE, Liu KC, Gupta D, Carlson AN, Asrani SG, Kim T. Reticular bullous epithelial edema in corneas treated with netarsudil: A case series. Am J Ophthalmol. 2020;217:20–6. - PubMed
    1. Macsai MS, Shiloach M. Use of topical rho kinase inhibitors in the treatment of fuchs dystrophy after descemet stripping only. Cornea. 2019;38:529–34. - PubMed